Monument Biosciences
Neurology & CNS Therapeutics · Biotechnology
$16.1Mtotal raised · 2 rounds on record
$5.8Mlatest round · Venture round · Jan 2023 · 3 yr ago
1backers · Elevate Ventures
10+team · employees, estimated range
Overview
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
Key facts
These are the key facts about Monument Biosciences on Alion as of Nov 13, 2026. Monument Biosciences is headquartered in New York, United States. It was founded in 2018. It has raised $16.1M in 2 funding rounds. The latest round is Venture - Series Unknown of $5.8M, announced in 2023.
- Headquarters
- New York, United StatesAlion company profile, updated Nov 4, 2026
- Founded
- 2018Alion company profile, updated Nov 4, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $16.1MSum of 2 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $5.8M · Jan 24, 2023SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$16.1M
2 rounds on record
Latest round
$5.8M
Venture round · Jan 2023 · 3 yr ago
Team
11-50
employees, estimated range
Backers
1
Elevate Ventures
The money's age
Long since its last round
45 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 24, 2023
Raised a round Venture round $5.8M · SEC Form D
Nov 4, 2020
Raised a round Venture round $10.3M · SEC Form D
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2023 | $5.8M | — | SEC Form D |
| Venture round | Nov 2020 | $10.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Monument Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Justin GellerExecutive Officer, DirectorSEC Form D
Michael RussellExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Vanqua Bio
backs NRG Therapeutics
Similar startupsby what they do, their industry and backers
Restoring energy. Next-generation disease-modifying medicines for ALS and Parkinson's.
Early answers. Better outcomes. Discover how ALZpath is changing Alzheimer’s diagnosis through scalable blood testing.
Precision Brain Access for Deep Brain Therapies Millions of patients with Parkinson's disease, Alzheimer's disease, brain cancer, epilepsy…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
Giving back control to patients with uncontrolled epilepsy. At Neurava, we empower individuals with epilepsy to reclaim their lives with…
People
Justin Geller
Executive Officer, Director
Michael Russell
Executive Officer, Director
Taylor Greene
Director
Ally Tam
Director
Amit Klein
Director
Dhruv Bansal
Director
Michael Mann
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Elevate VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
10-50 est. staff
How to cite this page
Alion, "Monument Biosciences: key facts", as of Nov 13, 2026. https://alion.io/company/monument-biosciences
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0